Ryota Nishimori

Net worth: 623 212 $ as of 2024-03-30

56 year

Technology Services

Profile

Ryota Nishimori is currently the President & Representative Director at CAC Holdings Corp.
since 2021 and the President & Representative Director at CAC Corp.
(Japanese) since 2014.
He previously served as the President & Director at CAC America Corp.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CAC HOLDINGS CORPORATION 0.23%	2022-12-30	48,000 ( 0.23% )	623 212 $	2024-03-30

Ryota Nishimori active positions

Companies	Position	Start
CAC HOLDINGS CORPORATION	President	2020-12-31
CAC KK CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014.	President	2014-03-31

All active positions of Ryota Nishimori

Former positions of Ryota Nishimori

Companies	Position	End
CAC America Corp.	President	-

See the detail of Ryota Nishimori's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ryota Nishimori's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CAC HOLDINGS CORPORATION	Technology Services

Private companies	2
CAC America Corp.
CAC KK CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014.	Technology Services